Orazinc

Pronunciation: zink SUL-fate
Generic Name: Zinc Sulfate
Brand Name: Examples include Orazinc and Zincate

Orazinc is used for:

Treating zinc deficiency. It may also be used for other conditions as determined by your doctor.

Orazinc is a mineral. It works by replacing zinc in the body.

Do NOT use Orazinc if:

• you are allergic to any ingredient in Orazinc

Contact your doctor or health care provider right away if any of these apply to you.

Before using Orazinc:

Some medical conditions may interact with Orazinc. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances (including dairy products)


• if you have low levels of copper in the blood

Some MEDICINES MAY INTERACT with Orazinc.

Ask your health care provider if Orazinc may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Orazinc:

Use Orazinc as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Orazinc by mouth with a meal.


• Avoid taking Orazinc at the same time as foods that contain bran, calcium, or phosphorus. They may decrease the amount of Orazinc absorbed into the body.


• If you take eltrombopag, a quinolone antibiotic (eg, levofloxacin), or a tetracycline antibiotic (eg, doxycycline), ask your doctor or pharmacist how to take it with Orazinc.


• If you miss a dose of Orazinc, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Orazinc.

Important safety information:

• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.


• Orazinc should not be used in CHILDREN younger than 12 years old without first checking with the child's doctor; safety and effectiveness in these children has not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Orazinc while you are pregnant. Orazinc is found in breast milk. If you are or will be breast-feeding while you use Orazinc, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Orazinc:

All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Nausea; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); severe vomiting; unusual restlessness; very dry mouth, eyes, or skin.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Orazinc side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include severe vomiting; unusual restlessness; unusual tiredness or weakness; or very dry mouth, eyes, or skin.

Proper storage of Orazinc:

Store Orazinc at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Orazinc out of the reach of children and away from pets.

General information:

• If you have any questions about Orazinc, please talk with your doctor, pharmacist, or other health care provider.


• Orazinc is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Orazinc. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Orazinc resources

• Orazinc Side Effects (in more detail)
• Orazinc Use in Pregnancy & Breastfeeding
• Orazinc Drug Interactions
• Orazinc Support Group
• 0 Reviews for Orazinc - Add your own review/rating

• Orazinc Concise Consumer Information (Cerner Multum)

Compare Orazinc with other medications

• Vitamin/Mineral Supplementation and Deficiency

Aceglatone

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000642-83-1

Chemical Formula

C10-H10-O8

Molecular Weight

258

Therapeutic Category

Enzyme inhibitor, ß-glucuronidase

Chemical Name

D-Glucaric acid, di-þ-lactone, 2,5-diacetate

Foreign Names

• Aceglatonum (Latin)
• Aceglaton (German)
• Acéglatone (French)
• Aceglatona (Spanish)

Generic Name

• Aceglatonum (IS)

Brand Name

• Glucaron
  Chugai, Japan

International Drug Name Search

Glossary

IS	Inofficial Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Gemfibrozil Actavis

Gemfibrozil Actavis may be available in the countries listed below.

Ingredient matches for Gemfibrozil Actavis

Gemfibrozil

Gemfibrozil is reported as an ingredient of Gemfibrozil Actavis in the following countries:

• Netherlands

International Drug Name Search

Cibace

Cibace may be available in the countries listed below.

Ingredient matches for Cibace

Benazepril

Benazepril hydrochloride (a derivative of Benazepril) is reported as an ingredient of Cibace in the following countries:

• South Africa

International Drug Name Search

Medizapin

Medizapin may be available in the countries listed below.

Ingredient matches for Medizapin

Olanzapine

Olanzapine is reported as an ingredient of Medizapin in the following countries:

• Peru

International Drug Name Search

ratio-Oxycocet

ratio-Oxycocet may be available in the countries listed below.

Ingredient matches for ratio-Oxycocet

Oxycodone

Oxycodone hydrochloride (a derivative of Oxycodone) is reported as an ingredient of ratio-Oxycocet in the following countries:

• Canada

Paracetamol

Paracetamol is reported as an ingredient of ratio-Oxycocet in the following countries:

• Canada

International Drug Name Search

Dival

Dival may be available in the countries listed below.

Ingredient matches for Dival

Diclofenac

Diclofenac diethylamine (a derivative of Diclofenac) is reported as an ingredient of Dival in the following countries:

• Venezuela

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Dival in the following countries:

• Venezuela

International Drug Name Search

Paracetamol Stada

Paracetamol Stada may be available in the countries listed below.

Ingredient matches for Paracetamol Stada

Paracetamol

Paracetamol is reported as an ingredient of Paracetamol Stada in the following countries:

• Germany

International Drug Name Search

l-Isoprenaline Hydrochloride

l-Isoprenaline Hydrochloride may be available in the countries listed below.

Ingredient matches for l-Isoprenaline Hydrochloride

Isoprenaline

l-Isoprenaline Hydrochloride (JAN) is also known as Isoprenaline (Rec.INN)

International Drug Name Search

Glossary

JAN	Japanese Accepted Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Methandienone

Methandienone may be available in the countries listed below.

Ingredient matches for Methandienone

Metandienone

Methandienone (BAN) is also known as Metandienone (Prop.INN)

International Drug Name Search

Glossary

BAN	British Approved Name
Prop.INN	Proposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Dacmozen

Dacmozen may be available in the countries listed below.

Ingredient matches for Dacmozen

Dactinomycin

Dactinomycin is reported as an ingredient of Dacmozen in the following countries:

• India

International Drug Name Search

Cyclospray

Cyclospray may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cyclospray

Chlortetracycline

Chlortetracycline hydrochloride (a derivative of Chlortetracycline) is reported as an ingredient of Cyclospray in the following countries:

• Belgium


• Switzerland

International Drug Name Search

Vanity

Vanity may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vanity

Dimpylate

Dimpylate is reported as an ingredient of Vanity in the following countries:

• Portugal

International Drug Name Search